Covid-19 Impact on Single-Cell Analysis Market, Global Research Reports 2020-2021
- 1.4.1 Research Process
- 1.4.2 Data Triangulation
- 1.4.3 Research Approach
- 1.4.4 Base Year
- 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
- 1.5.2 Covid-19 Impact: Commodity Prices Indices
- 1.5.3 Covid-19 Impact: Global Major Government Policy
2 Global Single-Cell Analysis Quarterly Market Size Analysis
- 2.1 Single-Cell Analysis Business Impact Assessment - COVID-19
- 2.1.1 Global Single-Cell Analysis Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.2 Global Single-Cell Analysis Quarterly Market Size 2020-2021
- 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
- 2.3.1 Drivers
- 2.3.2 Restraints
- 2.3.3 Opportunities
- 2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
- 3.1 By Players, Global Single-Cell Analysis Quarterly Market Size, 2019 VS 2020
- 3.2 By Players, Single-Cell Analysis Headquarters and Area Served
- 3.3 Date of Key Players Enter into Single-Cell Analysis Market
- 3.4 Key Players Single-Cell Analysis Product Offered
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Single-Cell Analysis Segments, By Type
- 4.1 Introduction
- 1.4.1 Consumables
- 1.4.2 Instruments
- 4.2 By Type, Global Single-Cell Analysis Market Size, 2019-2021
5 Impact of Covid-19 on Single-Cell Analysis Segments, By Application
- 5.1 Overview
- 5.5.1 Cancer
- 5.5.2 Neurology
- 5.5.3 Others
- 5.2 By Application, Global Single-Cell Analysis Market Size, 2019-2021
- 5.2.1 By Application, Global Single-Cell Analysis Market Size by Application, 2019-2021
6 Geographic Analysis
- 6.1 Introduction
- 6.2 North America
- 6.2.1 Macroeconomic Indicators of US
- 6.2.2 US
- 6.2.3 Canada
- 6.3 Europe
- 6.3.1 Macroeconomic Indicators of Europe
- 6.3.2 Germany
- 6.3.3 France
- 6.3.4 UK
- 6.3.5 Italy
- 6.4 Asia-Pacific
- 6.4.1 Macroeconomic Indicators of Asia-Pacific
- 6.4.2 China
- 6.4.3 Japan
- 6.4.4 South Korea
- 6.4.5 India
- 6.4.6 ASEAN
- 6.5 Rest of World
- 6.5.1 Latin America
- 6.5.2 Middle East and Africa
7 Company Profiles
- 7.1 Merck
- 7.1.1 Merck Business Overview
- 7.1.2 Merck Single-Cell Analysis Quarterly Revenue, 2020
- 7.1.3 Merck Single-Cell Analysis Product Introduction
- 7.1.4 Merck Response to COVID-19 and Related Developments
- 7.2 Thermo Fisher Scientific
- 7.2.1 Thermo Fisher Scientific Business Overview
- 7.2.2 Thermo Fisher Scientific Single-Cell Analysis Quarterly Revenue, 2020
- 7.2.3 Thermo Fisher Scientific Single-Cell Analysis Product Introduction
- 7.2.4 Thermo Fisher Scientific Response to COVID-19 and Related Developments
- 7.3 Becton Dickinson
- 7.3.1 Becton Dickinson Business Overview
- 7.3.2 Becton Dickinson Single-Cell Analysis Quarterly Revenue, 2020
- 7.3.3 Becton Dickinson Single-Cell Analysis Product Introduction
- 7.3.4 Becton Dickinson Response to COVID-19 and Related Developments
- 7.4 Beckman Coulter
- 7.4.1 Beckman Coulter Business Overview
- 7.4.2 Beckman Coulter Single-Cell Analysis Quarterly Revenue, 2020
- 7.4.3 Beckman Coulter Single-Cell Analysis Product Introduction
- 7.4.4 Beckman Coulter Response to COVID-19 and Related Developments
- 7.5 Bio-Rad Laboratories
- 7.5.1 Bio-Rad Laboratories Business Overview
- 7.5.2 Bio-Rad Laboratories Single-Cell Analysis Quarterly Revenue, 2020
- 7.5.3 Bio-Rad Laboratories Single-Cell Analysis Product Introduction
- 7.5.4 Bio-Rad Laboratories Response to COVID-19 and Related Developments
- 7.6 Qiagen
- 7.6.1 Qiagen Business Overview
- 7.6.2 Qiagen Single-Cell Analysis Quarterly Revenue, 2020
- 7.6.3 Qiagen Single-Cell Analysis Product Introduction
- 7.6.4 Qiagen Response to COVID-19 and Related Developments
- 7.7 Illumina
- 7.7.1 Illumina Business Overview
- 7.7.2 Illumina Single-Cell Analysis Quarterly Revenue, 2020
- 7.7.3 Illumina Single-Cell Analysis Product Introduction
- 7.7.4 Illumina Response to COVID-19 and Related Developments
- 7.8 GE Healthcare
- 7.8.1 GE Healthcare Business Overview
- 7.8.2 GE Healthcare Single-Cell Analysis Quarterly Revenue, 2020
- 7.8.3 GE Healthcare Single-Cell Analysis Product Introduction
- 7.8.4 GE Healthcare Response to COVID-19 and Related Developments
- 7.9 Agilent Technologies
- 7.9.1 Agilent Technologies Business Overview
- 7.9.2 Agilent Technologies Single-Cell Analysis Quarterly Revenue, 2020
- 7.9.3 Agilent Technologies Single-Cell Analysis Product Introduction
- 7.9.4 Agilent Technologies Response to COVID-19 and Related Developments
- 7.10 Fluidigm Corporation
- 7.10.1 Fluidigm Corporation Business Overview
- 7.10.2 Fluidigm Corporation Single-Cell Analysis Quarterly Revenue, 2020
- 7.10.3 Fluidigm Corporation Single-Cell Analysis Product Introduction
- 7.10.4 Fluidigm Corporation Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
- 9.1 About US
This report covers market size and forecasts of Single-Cell Analysis, including the following market information:
Global Single-Cell Analysis Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Single-Cell Analysis Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Single-Cell Analysis Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Single-Cell Analysis Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Key market players
Major competitors identified in this market include Merck, Thermo Fisher Scientific, Becton Dickinson, Beckman Coulter, Bio-Rad Laboratories, Qiagen, Illumina, GE Healthcare, Agilent Technologies, Fluidigm Corporation, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Consumables
Instruments
Based on the Application:
Cancer
Neurology
Others